Panzyga (Human Normal Immunoglobulin)

Human Normal Immunoglobulin, the active ingredient in Panzyga, is an Immunoglobulin presented as a unknown/intravenous solution for intravenous use. It replaces deficient antibodies and is used in primary immunodeficiency disorders and certain immune‑mediated conditions in both children and adults.

GNH USA supplies Panzyga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Panzyga is an immunoglobulin therapy that provides passive immunity for patients with antibody deficiencies. It is indicated for: - Primary immunodeficiency diseases (PID): Reduces the frequency and severity of infections by supplying functional antibodies. - Secondary immunodeficiency following bone‑bone marrow transplant or chemotherapy of the myeloabl my ​     ...  ...  … . - Chronic immune medi …  …  …  ....  …  …  … …  …  …  … …  …  … -  … …  .... …  … ...  ... ...

Common      … ​ … … ... 

...